Alex Drinkall, 24 March 2020
Health Education England elearning for healthcare (HEE elfh) has created an elearning programme in response to the Coronavirus (COVID-19) global pandemic that is free to access, without logging in*, for the entire UK health and care workforce, including those working in the NHS, the independent sector and social care.
The programme includes key materials to help the health and care workforce respond to Coronavirus.
The Coronavirus programme currently includes limited resources, but we will add more content in the coming days and weeks. The additional content will include new sessions and content curated from different sources such as existing HEE elfh sessions and materials from other organisations such as NHS England and NHS Improvement or the World Health Organization.
Content in the Coronavirus programme currently includes:
- Essential Guidance from the NHS, Government and WHO
- Infection Prevention and Control
- Personal Protection Equipment
- Critical Care Resources
- RCGP learning
- Invasive Ventilation
- Intensive Care Medicine
- Anaesthesia
- Induction of International and Returning GPs
- Statutory and Mandatory Training
HEE elfh has removed the requirement to log in to access the Coronavirus (COVID-19) programme to make it as easy as possible for the health and care workforce to access the learning resources. However, be aware that accessing the content without logging in means that your learning activity won’t be tracked and you won’t create a learning record. If you wish to have a learning record to demonstrate your compliance you will need to have an elfh account and be logged in. You can register for an elfh account using any email address.
For more information about the programme, which is free for the health and care workforce to access without the need to register, visit www.e-lfh.org.uk/coronavirus .
Another HEE resource, SCRIPT elearning, is now freely available to anyone with a NHS email address. For more information visit www.safepresciber.org, email info@safeprescriber.org and or follow @safeprescriber on Twitter.
Comments are closed.